Skip to Content

Uncategorized Document

Sandoz Pharmaceuticals Corp.; Bromocriptine Mesylate (Parlodel) for the Prevention of Physiological Lactation; Opportunity for a Hearing on a Proposal To Withdraw Approval of the Indication

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Visit or use the printed Federal Register if you need an official format.

The full text of this document is currently only available in a basic text format.